AtriCure, Inc.
AtriCure (Nasdaq: ATRC) develops and sells medical devices for surgical treatment of atrial fibrillation, left atrial appendage management and post-operative pain management. Its cardiac ablation devices are used by surgeons in open-heart and minimally invasive procedures, while its AtriClip system mechanically… From the company’s description.
Over the twelve months to Sep 30, 2026, AtriCure, Inc. reported revenue of $589.80M, up 13.8% from a year earlier, and net income of $14.88M. Its operating margin was 2.9%, and operations generated $68.55M in cash. In fiscal 2025, it reported revenue of $534.53M, up 14.9% from fiscal 2024, and a net loss of $11.45M.
Margins and return on equity change in ; everything else in percent. Fewer shares and less debt are shown plainly, not as bad news — it depends what you make of buybacks. Dotted labels explain each measure. is shown separately from the annual figures.
What AtriCure, Inc. does
In the company’s own words
AtriCure (Nasdaq: ATRC) develops and sells medical devices for surgical treatment of atrial fibrillation, left atrial appendage management and post-operative pain management. Its cardiac ablation devices are used by surgeons in open-heart and minimally invasive procedures, while its AtriClip system mechanically excludes the left atrial appendage to help address stroke risk. Cryo Nerve Block products temporarily freeze peripheral nerves to relieve pain after cardiac, thoracic and amputation surgeries. Customers are medical centers, served directly in the United States and selected international markets and through distributors elsewhere. AtriCure’s product portfolio includes Isolator Synergy and EnCompass ablation clamps, EPi-Sense systems, AtriClip devices, and cryoSPHERE and cryoXT probes. The company reports its business as one operating segment. In fiscal 2025, revenue was approximately $556 million, and its U.S. and international sales teams included approximately 405 employees. Its website is www.atricure.com.
Company details
- Sector
- Health Care
- Industry (SIC)
- Surgical & Medical Instruments
- Headquarters
- MASON, OH
- Fiscal year end
- December
- CIK
- 1323885
- SIC
- 3841
Financial performance, year by year
Fiscal 2011–2025 · USDThe full income statement, balance sheet and cash flow for each of these years — every figure traceable to its filing — is on the Financials tab with a free account.
Who owns AtriCure, Inc. — and what changed
Funds as of 2026Q2 · superinvestors as of 2026-06-30
Largest fund holders · AtriCure, Inc.’s weight in each
Fund ownership is a floor, not a census — pensions, insurers and people holding shares directly are not visible here.
Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.
Every fund and institutional holder, quarter by quarter, is on the Ownership tab with a free account.
Recent filings
All filings →Each filing opens into its own statements and disclosures here.
Put this business in context.
Compare this company with peers, find it in your funds and follow its financial history with your connected AI:
- “How do AtriCure, Inc. and its peers compare on margins and cash generation over ten years?”
- “Where did five years of AtriCure, Inc.'s earnings go — cash, debt, buybacks, reinvestment?”
- “What changed in AtriCure, Inc.'s last four quarterly filings that the numbers alone won't show?”